Cargando…
Identification and validation of molecular subtypes and a 9-gene risk model for breast cancer
The long-term efficacy of treatment, heterogeneity, and complexity in the tumor microenvironment remained a clinical challenge in breast cancer (BRCA). There is a need to classify and refine appropriate therapeutic intervention decisions. A stable subtype classification based on gene expression asso...
Autor principal: | Feng, Jiexin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519538/ https://www.ncbi.nlm.nih.gov/pubmed/37747033 http://dx.doi.org/10.1097/MD.0000000000035204 |
Ejemplares similares
-
Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population
por: Wang, Jiayu, et al.
Publicado: (2016) -
Prognostic significance of molecular subtype, metastatic site and primary tumor surgery for survival in primary metastatic breast cancer: A SEER-based study
por: Li, Yang, et al.
Publicado: (2021) -
Screening and identification of hub-gene associated with brain metastasis in breast cancer
por: Li, Xiao-Gang, et al.
Publicado: (2023) -
Association Between Insulin Resistance and Luminal B Subtype Breast Cancer in Postmenopausal Women
por: Nam, Sanggeun, et al.
Publicado: (2016) -
Brain metastasis with subtype conversion in a patient with male breast cancer: A case report
por: Oh, Byeong Ho, et al.
Publicado: (2021)